Quick Answer
Tyra Biosciences, Inc. reported Operating Income of -$132.76 million for fiscal year 2025.
Tyra Biosciences, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$132.76M | -27.4% |
| 2024 | -$104.18M | -30.3% |
| 2023 | -$79.94M | -35.7% |
| 2022 | -$58.93M | -124.2% |
| 2021 | -$26.29M | -182.8% |
| 2020 | -$9.30M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$32.94M | -15.2% | -4.7% |
| June 30, 2025 | -$31.45M | -33.7% | +1.2% |
| March 31, 2025 | -$31.85M | -42.7% | -11.3% |
| September 30, 2024 | -$28.60M | -19.4% | -21.6% |
| June 30, 2024 | -$23.53M | -46.9% | -5.4% |
| March 31, 2024 | -$22.32M | -55.7% | +6.8% |
| September 30, 2023 | -$23.96M | -75.6% | -49.6% |
| June 30, 2023 | -$16.01M | -3.8% | -11.7% |
- Tyra Biosciences, Inc. showed a decrease of -27.4% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, Tyra Biosciences, Inc.’s operating income has declined by 1328.0% (from -$9.30 million to -$132.76 million).
- The most recent figure is from Tyra Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: